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Objective: Small animal models are commonly employed to study progression of and potential treatment
techniques for degenerative disc disease (DDD), but assessment using conventional imaging techniques
is challenging due to resolution. The objective of this study was to employ equilibrium partitioning of an
ionic contrast agent micro computed tomography (EPIC - mCT) to map three-dimensional (3D) degen-
erative changes in the rabbit intervertebral disc (IVD).
Materials and methods: In vivo degeneration was induced surgically in 12 New Zealand White rabbits via
percutaneous annular puncture and percutaneous nucleotomy. IVDs were harvested after 3 and 6 weeks.
EPIC-mCT imaging was performed on fresh, IVDs before and after formalin ﬁxation, and 3D IVD volumes
were segmented. IVDs were histologically stained with Safranin-O/Fast-Green and Hematoxylin & Eosin
(H&E). EPIC-mCT attenuation and 3D morphological measurements were assessed in healthy and
degenerate IVDs and compared to qualitative grading and disc height measurement from histology.
Results: EPIC-mCT caused pronounced contrast enhancement of the IVD. Annular puncture and nucle-
otomy produced mild and severe degenerative changes, respectively. IVD attenuation following contrast
enhancement increased signiﬁcantly in nucleotomized discs at 3 and 6 weeks. IVD attenuation correlated
signiﬁcantly with histologic score and disc height measurements. Disc height decreased most extensively
in the posterior and lateral aspects of the IVD. 3D morphological measurements correlated strongly to
IVD attenuation and were more sensitive to degenerative changes than histologic measurements.
Formalin ﬁxation reduced the attenuation of IVDs by ~10%.
Conclusion: EPIC-mCT is sensitive to in vivo DDD induced by nucleotomy and provides a high resolution
3D method for mapping degenerative changes in rabbit IVDs.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Degenerative disc disease (DDD) is a common though debili-
tating condition that is characterized at the tissue level by signiﬁ-
cant structural and biochemical changes. To study the
pathomechanics of DDD and potential treatment strategies, pre-
clinical research with small animal models are commonly
employed. Several small-animal intervertebral disc (IVD) models
have been shown to possess similar disc anatomy, biomechanicalto: K.C. Baker, Orthopaedic
W Thirteen Mile Road, Royal
-551-0191.
Baker).
ternational. Published by Elsevier Lproperties, biochemical composition and water content to human
IVDs1 and have been utilized to study DDD both in vivo and
in vitro2e10.
Quantitative imaging can provide important information
regarding the efﬁcacy of a regenerative modality and/or the extent
of a degenerative condition. Magnetic resonance imaging (MRI)
techniques, such as delayed gadolinium-enhanced MRI (dGEM-
RIC),T1-rho and T2*-weighted sequences, which are capable of
sensitive, quantitative characterization of structural and biochem-
ical changes in human cartilagenous structures, have been tradi-
tionally employed in the imaging of the IVD11e18. Except for very
high-ﬁeld magnet systems, the in-plane resolution of these tech-
niques is generally limited to hundreds of microns and produce
slice thicknesses ranging from hundreds of microns to single mil-
limeters, making them less than ideal for the characterization oftd. All rights reserved.
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mography (mCT) has been utilized extensively in preclinical sce-
narios involving small animals and is capable of acquiring 3D data
sets with resolutions far exceeding those obtained with MRI tech-
niques. Despite the promise of mCT, its applicability in the study of
DDD or IVD regeneration has been limited by the low X-ray
attenuation of cartilaginous and ﬁbrocartilagenous tissues19e23.
Altering the X-ray attenuation properties of the IVD via contrast-
enhancement may provide an avenue by which mCT could be
employed in the characterization of DDD in small animal models.
Contrast-enhanced mCT techniques offer wider applicability in
morphological and molecular characterization of soft tissues, and
they have been previously employed in the characterization of
sulfated glycosaminoglycan (sGAG) concentration and distribution
within articular cartilage. One such contrast-enhancing technique,
called equilibrium partitioning of an ionic contrast agent-
enhanced-micro-computed tomography (EPIC-mCT), provides
contrast-enhanced 3D data of sGAG content due to the preferential
exclusion of the anionic contrast agent ioxaglate (Hexabrix©,
Guerbert LLC, Bloomington, IN, USA) from negatively charged,
sGAG-rich tissue20,21,24,25. Electrostatic repulsion of the iodinated
contrast agent results in an inverse relationship between sGAG
content and X-ray attenuation due to the concentration of iodine
atoms in sGAG-poor regions following incubationwith the contrast
agent. Palmer, Guldberg and Levenston were the ﬁrst to demon-
strate EPIC-mCT as a technique to detect degenerative changes in
sGAG content in rat and mouse femoral articular cartilage20. Other
studies have used EPIC-mCT to characterize articular cartilage in
lapine, murine models19e25 and it has also been applied in the
setting of murine xiphoid26 and caprine osteochondral defects of
the talus27.
The loss of sGAGs in the IVD is a landmark sign of DDD in both
humans and in animal models. Progressive dehydration and
breakdown of the sGAG-rich matrix of the nucleus pulposus (NP)
leads to a loss in mechanical properties and disc height, which
perpetuate the DDD cascade. High resolution, 3D imaging of the
concentration and spatial distribution of sGAGs within the IVD of
small animal models has the potential to provide new insights
about the onset and progression of DDD, as well as the efﬁcacy of
new regenerative strategies. To date, EPIC-mCT has not been used to
image the IVD or DDD-associated changes in sGAG concentrations
within the IVD. This study aimed to use EPIC-mCT to characterize 3D
morphology andmap in vivo degenerative changes in the rabbit IVD
and to validate the technique using conventional histologic
characterization.Methods
In vivo surgical degeneration model
Under an Institutional Animal Care and Use Committee (IACUC)-
approved protocol, IVD degeneration was induced in vivo via two
surgical models: percutaneous annular puncture (Puncture) and
percutaneous nucleotomy (Nucleotomy), as previously
described2,6,28,29. All surgeries were carried out by a fellowship-
trained orthopedic spine surgeon. Four lumbar IVDs (L1/L2
through L4/L5) from each of 12 New Zealand White rabbits were
used. An 18-gauge needle was used to perform a nucleotomy at one
lumbar disc, while one other randomized, nonadjacent lumbar disc
underwent annular puncture with a 18-gauge needle. Both the
Puncture and Nucleotomy defects were performed using a percu-
taneous, lateral approach under ﬂuoroscopy. The remaining two
uninjured discs were used as healthy internal controls. This
randomization protocol was used to minimize confoundingdegenerative effects in adjacent segments9,28 while allowing each
treated disc to be imaged with an adjacent, healthy control.
Rabbits were allowed ad libitum postoperative cage activity until
sacriﬁce at 3-weeks (n ¼ 6 rabbits) and 6-weeks (n ¼ 6 rabbits).
Following necropsy, lumbar spines were aseptically-harvested en
bloc and sectioned with a dissection bandsaw (Bone Band Saw, In-
ternationalMedical Equipment, SanMarcos, CA, USA) into segments
containing two discs, leaving half of the cranial and caudal vertebral
bodies intact. All specimens were then incubated in 50% (v/v) iox-
aglate (Hexabrix©, Guerbet LLC, Bloomington, IN, USA) in phosphate
buffered saline (PBS) supplemented with protease inhibitors (Sig-
maFAST Protease Inhibitor Tablets, Sigma Aldrich) for 24 h at room
temperature. Samples were then removed from solution, dabbed
lightly, wrapped in moist towels, and mounted on the mCT stage. All
scans were performed using a mCT (Triumph Trimodality, Gamma
Medica, Salem,NH,USA)with a 100mmisotropic voxel size,11bin,
ﬁve frame averaging, 2.0 zoom factor, at 60 kVp and 470 mA. Air and
purewater standardswere used to calibrate each scan to Hounsﬁeld
Units (HU). To account for biologic and scan-to-scan variability, each
injured disc was scanned together with an adjacent healthy disc in
order to allow normalization to healthy controls.
Effect of formalin ﬁxation on IVD attenuation
To determine the effect of formalin ﬁxation on absolute atten-
uation and differences between groups, all samples were imaged
following ﬁxation. After the initial, fresh scan, all IVDs were ﬁxed in
10% neutral buffered formalin for 72 h, rinsed in distilled water,
rehydrated in sterile PBS, and re-imaged using the same contrast
agent incubation and imaging protocol.
mCT image processing and analysis
After imaging, three-dimensional (3D) IVD volumes were iso-
lated for each sample using a semi-automated routine in Mimics
image processing software (Materialise, Inc, Leuven, Belgium).
Brieﬂy, the user deﬁned a seed point in the center of the IVD around
which an automated region-growing algorithm was applied, fol-
lowed by an automated edge detection algorithm. Accuracy of the
isolationwas conﬁrmed in all three planes, and manual corrections
of the isolationswere performed at interfaces where edge detection
caused erroneous isolation. Isolated volumes were exported to
MATLAB (Mathworks, Inc., Natick, MA, USA) where voxel-by-voxel
averaging was performed on attenuation data to calculate whole
IVD attenuation. Total disc volume was calculated in MATLAB using
the known voxel size. Whole-IVD axial height maps were calcu-
lated as the height of the cranial-caudal voxel column (Fig. 2). Using
a custom MATLAB program, these height maps were split into four
zones: anterior (ant), posterior (post), NP and lateral (lat) (Fig. 2).
The NP zone was determined based on previously described geo-
metric proportions30, by scaling the shape of the IVD by previously
described lateral and AP width ratios and A/P centroid offset. The
two lateral zones were deﬁned as the zones outside of the direct
anterior-to-posterior lines at the lateral edges of the NP. The
anterior and posterior zones were deﬁned as the zones bound by
the NP and lateral zone boundaries (Fig. 2).
Contrast uptake ratio (CUR) provides a measure of preferential
uptake or exclusion of ionic contrast agents by tissue31. Anionic
contrast agents have CUR > 1, indicating preferential exclusion. CUR
was calculated for thewhole IVD, NP, and annulusﬁbrosus (AF) of all
control discs as a measure of the relative exclusion of the different
regions of the disc. The NP was approximated for the entire volume
based onpreviously described geometric proportions30 and analysis
of NP geometry on histologic slices, while the AF was deﬁned as the
whole IVD volume outside of the NP.
Fig. 1. Non-contrast-enhanced IVD (A); Contrast-enhanced IVD (B), with the edges of the IVD shown by a dotted line; Distributions of whole IVD attenuation in contrast-enhanced
IVD compared to non-contrast-enhanced IVD demonstrates a pronounced shift in the distribution of attenuation data without overlapping with the attenuation spectrum of bone
(C).
Fig. 2. Height maps calculated from segmented IVDs. 3D segmentation enabled accurate calculations of height maps to analyze zonal differences in disc height. Both disc height and
disc volume calculated from segmented EPIC-mCT data sets correlated signiﬁcantly with disc height measured on histology.
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Following ﬁxation, IVDs were decalciﬁed, embedded in parafﬁn,
cut into 5 mm sagittal sections, and mounted on glass slides. Nine
sections spaced ~30 mm were taken from the center of each disc,
seven sections were stained with Safranin-O/Fast-Green (Saf-O),
and two sections were stained with Hematoxylin and Eosin (H&E).
Slides were imaged using light microscopy at 4 magniﬁcation.
Qualitative histological grading of Saf-O stained slices was per-
formed by two experienced researchers under blinded conditions.
Histologic sections were graded using the classiﬁcation system
developed by Rutges et al.32. This 12-point classiﬁcation system has
been shown to accurately characterize DDD by using a classiﬁcation
of morphology, cellularity, and stain intensity of the NP, AF and
endplates. This system has demonstrated signiﬁcant correlation to
sGAG content and higher inter- and intra-observer reliability than
previous classiﬁcation systems32. Intraclass correlation coefﬁcients
(ICC) were calculated to determine the level of agreement between
blinded graders.
Disc height was measured on sagittal histologic sections (n ¼ 3
per animal) at the center of the disc, deﬁned as the halfway point
between the anterior and posterior edges. A custom MATLAB pro-
gram was used to manually outline the entire disc, and disc height
was automatically calculated based on the mean of anterior, center,
and posterior disc height measurements. To validate this program,
results of the automated disc height measurements were compared
to manual measurements performed on n¼ 48 measurements, and
an intraclass correlation coefﬁcient of 0.904 (P < 0.001) was
calculated between the two analyses.
Data comparisons and statistical methods
All data was analyzed using SPSS (v20, IBM, Armonk, NY).
Normality and equal variance assumptions were conﬁrmed using
the KolmorogoveSmirnov test and Levene's test for equality of
variances, respectively. Correlations were calculated using thebivariate, two-tailed Pearson productemoment correlation coefﬁ-
cient (r). Consistent with previous studies assessing DDD9,28, each
treated IVD was paired with an adjacent, internal control IVD to
limit both animal-to-animal and scan-to-scan variability. Attenua-
tion of control IVDs at different disc levels were compared to assess
variability, and disc attenuation did not differ signiﬁcantly between
treatment levels (P ¼ 0.151) nor between groups (P ¼ 0.647). Dif-
ferences in all variables between treatment groups and internal
controls were assessed using matched-pair, two-tailed Student's t
tests with alpha ¼ 0.05. Aggregate results are reported as a mean
with a 95% conﬁdence interval [lower limit, upper limit].
Results
Characterization of the contrast-enhanced IVD
Contrast enhancement enabled accurate 3D segmentation and
subsequent characterization of the IVD. While accurate segmen-
tation of the IVD is not possible in non-contrast enhanced images
due to the lack of distinct tissue interfaces, the contrast enhanced
IVD is easily discerned from surrounding soft tissue and bordering
bony endplates. The spatial distribution of sGAGs within the IVD is
appreciated by distinct spatial differences in attenuation (Fig. 1).
The mean attenuation of the whole IVD, NP, and AF in the non-
contrast-enhanced IVD was 82.16 HU, 39.08 HU and
88.95 HU, respectively. Following contrast enhancement, there
was an increase in mean whole-IVD, NP, and AF attenuation to
488.92 HU [462.18, 515.6681], 318.17 HU [290.10, 346.25] and
518.71 HU [491.20, 546.22] (n¼ 24 for all), respectively [Fig.1(C)]. In
contrast-enhanced IVDs, the NP had signiﬁcantly lower mean
attenuation compared to the AF (P < 0.001), demonstrating an in-
verse relationship between sGAG content and contrast agent up-
take within the disc [Fig. 1(B)]. The attenuation of 50% ioxaglate
under the scan settings used in this study was 5308.2 HU. The
resulting CUR of 50% ioxaglate in control IVDs was 0.108 [0.103,
0.113] in the whole IVD, 0.053 [0.047, 0.058] in the NP, and 0.115
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signiﬁcantly lower than that of the AF (P < .001), conﬁrming pref-
erential exclusion of ioxaglate in sGAG rich areas.
Contrast enhancement also enabled morphological character-
ization of the IVD. A 2D height map calculated from 3D disc vol-
umes demonstrates differences in disc height as a function of zone
[Figs. 2 and 3(B)]. Disc height measured on histology correlated
strongly with disc height calculated from contrast enhanced image
sets (n¼ 48, Anterior zone: r¼ 0.448, P¼ 0.002; NP zone: r¼ 0.674,
P < 0.001; Posterior zone: r ¼ 0.826, P < 0.001; Overall mean:
r ¼ 0.752, P < 0.001). Total disc volume calculated from segmented
3D data sets correlated with mean disc height measured on his-
tology (n ¼ 48, r ¼ 0.633, P < 0.001) and disc height measured on
mCT (n ¼ 48, r ¼ 0.712, P < 0.001).
In vivo degeneration of the IVD
Nucleotomy induced more severe degenerative changes than
Puncture. The histologic grade of Puncture IVDs increased only
slightly at 3 weeks and signiﬁcantly at 6 weeks [Fig. 3(A)], while the
histologic grade of Nucleotomy IVDs signiﬁcantly increased at 3 and
6weeks compared to their respective controls [Fig. 3(A)]. Therewas
a very high level of agreement (n ¼ 48, ICC ¼ 0.989, P < 0.001)
between histologic raters. Disc height measured on mCT decreased
to a greater degree in the Nucleotomy group than in the Puncture
group at both 3 and 6 weeks [Fig. 3(B)]. A global decrease in disc
height is evident on calculated height maps, most notably in the
posterior and lateral aspect (Fig. 2). Furthermore, a pronounced loss
in disc height at the central aspect of the disc is observed in the
Nucleotomy group, consistent with changes due to the removal of
the NP. The greatest change in disc height was noted in the pos-
terior zone, where the Nucleotomy group decreased by 32.93%
[19.51, 46.36] (n ¼ 4, P ¼ 0.001) at 3 weeks and by 26.94% [1.61,
52.28] (n ¼ 5, P ¼ 0.040) at 6 weeks, and where the Puncture group
decreased by 21.40% [5.68, 37.13] (n ¼ 6, P ¼ 0.028) at 3 weeks and
non-signiﬁcantly by 20.04% [5.91, 46.01] (n ¼ 6, P ¼ 0.101) at 6
weeks. Mean disc height decreased signiﬁcantly in both groups at
both time points. There were strong inverse correlations between
disc height and qualitative histology score in both the Puncture
group (n ¼ 24, r ¼ 0.734, P < 0.001) and the Nucleotomy group
(n ¼ 21, r ¼ 0.747, P < 0.001). Mean disc height measured on
histology was less sensitive to degenerative changes, as mean discFig. 3. Rutges histologic score (A) and disc height measured on contrast-enhanced mCT (B)
signiﬁcant increases in histologic score at both 3- and 6-week time points. Puncture exhibited
in both Puncture and Nucleotomy at both time points, but the largest decreases were evident
and n ¼ 4 for 3 week Puncture and Nucleotomy, respectively. n ¼ 6 and n ¼ 5, for 6 weekheight was found to be signiﬁcantly reduced compared to controls
in only 3-week Puncture IVDs (n ¼ 6, 13.16%, [2.63, 23.71],
P ¼ 0.022) and 3-week Nucleotomy IVDs (n ¼ 4, 13.82%, [3.54,
24.10], P ¼ 0.036).
Degeneration of the IVD caused marked increases in average
mCT attenuation following contrast enhancement in the Nucleot-
omy group, with only minimal, non-signiﬁcant changes in the
Puncture group [Fig. 4(A)]. A shift in the distribution of attenuation
data can be observed in both the Puncture and Nucleotomy groups
[Fig. 4(B)], and this shift was more pronounced in the Nucleotomy
group. There were signiﬁcant increases in IVD attenuation of
Nucleotomy IVDs compared to controls at both 3 weeks (n ¼ 4,
21.81%, [10.75, 32.88], P¼ 0.011) and 6 weeks (n¼ 5, 22.83%,[5.79,
51.46], P ¼ 0.034), but this was not observed in the Puncture group
at either time point. There were signiﬁcant correlations between
histologic grade and IVD attenuation in both the Nucleotomy group
(n ¼ 21, r ¼ 0.547, P ¼ 0.006) and Puncture group (n ¼ 24, r ¼ 0.471,
P ¼ 0.023). 3D disc volume and disc height correlated signiﬁcantly
with IVD attenuation in only the Nucleotomy group (n ¼ 21, Disc
Volume: r ¼0.530, P¼ 0.008; Disc Height: r ¼0.467, P¼ 0.022).
Disc height measured on histology correlated signiﬁcantly with IVD
attenuation in both the Nucleotomy (n ¼ 21, r ¼ 0.559, P ¼ 0.005)
and Puncture group (n ¼ 24, r ¼ 0.522, P ¼ 0.011). The global
relationship between histologic disc height and attenuation as well
as mCT disc volume and attenuation is shownwith all discs grouped
(Fig. 5).
Comparisons between histologic images and mCT images
demonstrate that Puncture and Nucleotomy discs exhibit areas of
increased attenuation corresponding to areas of reduced staining
intensity on Saf-O-stained sections, most notably in Nucleotomy
discs [Fig. 6(C), (F)]. A distinct, well-hydrated NP is evident on
control histologic sections [Fig. 6(D), (G)], which corresponds to
areas of low attenuation on mCT images [Fig. 6(A)]. However,
degenerate discs exhibit decreased disc height and no distinct NP
[Fig. 6(H), (I)], corresponding to areas of increased attenuation on
mCT images [Fig. 6(B), (C)].
The effect of formalin ﬁxation on IVD attenuation
Formalin ﬁxation reduced whole-disc attenuation of all samples
by a mean 11.20% [7.70, 14.69] (n ¼ 48, Fresh: 509.00 HU, [483.71,
534.30]; Fixed: 447.27 HU, [425.97, 468.58], P < 0.001). There wasas a function of post-operative time point and treatment group. Nucleotomy exhibited
signiﬁcant increases in histologic score only at 6 weeks. Disc height decreased globally
in the Nucleotomy group, most notably in the posterior zone. * indicates P < 0.05. n ¼ 6
Puncture and Nucleotomy, respectively. Error bars represent 95% conﬁdence interval.
Fig. 4. Contrast-enhanced attenuation changes due to in vivo Nucleotomy and Puncture. There were signiﬁcant increases attenuation compared to internal controls in the
Nucleotomy group at both 3 and 6 weeks (A). Normalized histograms indicate a shift in attenuation data due to in vivo degeneration, most notably in the Nucleotomy group (B). *
indicates P < 0.05. n ¼ 6 and n ¼ 4 for 3 week Puncture and Nucleotomy, respectively. n ¼ 6 and n ¼ 5, for 6 week Puncture and Nucleotomy, respectively. Error bars represent 95%
conﬁdence interval.
Fig. 5. Scatter plots of histologic disc height vs whole IVD attenuation (A) and mCT disc volume vs whole IVD attenuation (B). IVD attenuation correlated signiﬁcantly with both disc
height and disc volume (n ¼ 48).
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ﬁxation between the NP (n ¼ 48, 13.14%, [7.78, 18.50]) and the AF
(11.09% [7.61, 14.57], P ¼ 0.336). Due to this reduction, ﬁxation
appears to decrease the sensitivity of EPIC-mCT to degenerative
changes of the IVD, as only the Nucleotomy group at 3 weeks
exhibited a signiﬁcant increase in attenuation over its matched
internal control in ﬁxed scans (n ¼ 4, 19.96% [1.00, 1.39] P ¼ 0.044).
No other direct comparisons were signiﬁcant. However, correla-
tions between IVD attenuation and metrics of degeneration
remained largely signiﬁcant following ﬁxation. IVD attenuation still
correlated signiﬁcantly to histologic score in both the Nucleotomy
group (n ¼ 21, r ¼ 0.539, P ¼ 0.007) and the Puncture group
(n ¼ 24, r ¼ 0.464, P ¼ 0.026).
Discussion
Advanced imaging techniques can provide 3D information
about extracellular matrix (ECM) composition of the IVD, but to
date, only MRI has proven sensitive to degenerative changes in
animal models of DDD11,13,15. Contrast-enhanced mCT, namely EPIC-
mCT, provides a non-destructive 3D technique for imaging sGAG
distributions in orthopedic soft tissues at a higher resolution thanMRI, and it has been described for the detection of sGAG changes in
degenerate articular cartilage of rats, mice, and goats19e21,23e25,27.
The present study characterized degenerative changes of the rabbit
IVD using EPIC-mCT in in vivo models of DDD. Our results indicate
that degenerative changes induce increases in contrast-enhanced
attenuation proportional to the degree of degeneration, and, to
the authors' knowledge, this is the ﬁrst study to describe the use of
EPIC-mCT in the IVD.
3D characterization of IVD morphology and attenuation affor-
ded by EPIC-mCT can augment other imaging techniques and/or
histologic staining in pre-clinical animal models of DDD. While
histology requires numerous sections to obtain representative in-
formation about a 3D volume, contrast-enhanced mCT is able to
obtain information from the entire disc volume. The equilibrium
partitioning of ioxaglate allows for relative spatial differences in
sGAG content to be appreciated, (Fig. 6), which enables accurate
characterization of changes in sGAG concentration or distribution
associated with IVD degeneration or regenerative techniques.
Compared to conventional mCT, EPIC-mCT provides pronounced
contrast enhancement of the IVD, clearly delineating the borders of
the IVD from surrounding tissues, thus enabling accurate 3D seg-
mentation of the entire disc volume. The present study
Fig. 6. Contrast-enhanced mCT colormaps (AeC), Saf-O-stained histologic sections (DeF) and H&E-stained histology sections (GeI) of representative control, Puncture, and
Nucleotomy IVDs. Decreased disc height and regions of increased attenuation can be observed in mCT colormaps of both the Puncture and Nucleotomy discs. These regions
correspond to the loss of disc height, loss of a healthy NP morphology, and changes in staining intensity indicative of degeneration observed in histologic sections.
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logical characterization of the IVD, such as quantiﬁcation of total
volume and disc height at various zones. Furthermore, disc height
measurements derived from this 3D volumeweremore sensitive to
degenerative changes than histologic measurement of disc height,
suggesting that whole-volume morphological assessment provides
more information about IVD degeneration than can be obtained
from single 2D sections.
Data from our study indicates that EPIC-mCT can detect degen-
erative changes which occur in vivo, most notably in nucleotomized
discs. Previous studies utilizing EPIC-mCT have demonstrated
increased attenuation due to various in vivo degeneration tech-
niques applied to articular cartilage, xyphoid, and talus degener-
ation25e27, and our study demonstrated similar ﬁndings in the IVD.
We found signiﬁcant correlations between mCTattenuation and disc
height, disc volume, and histologic score, indicating that as sGAG
content decreases due to degeneration, more contrast agent dif-
fuses into the disc volume, causing increased attenuation. In our
study, distinct loss of NP hydration, NP area, Saf-O stain intensity,
and changes in ECMmorphology were all noted on histologic slices
from nucleotomized IVDs, which was manifested in increased mCT
attenuation at both three and 6 weeks compared to control discs.
EPIC-mCT colormaps demonstrate areas of increasing attenuation
within the disc matrix, most notably in the center of the disc, which
corresponded to regions of decreased Saf-O staining on histologic
sections (Fig. 6).
Both in vivo surgical models used in this study have been used
extensively in literature as models of DDD. Annular puncture and
nucleotomy are physiologically relevant surgical methods for
inducing gradual, accumulative degradation and severe, traumatic
degradation, respectively, and are important tools for assessingregenerative treatments in an in vivo setting2,6e8,28,29. Nucleotomy
is known to induce a more rapid onset of degenerative changes due
to the complete removal of the NP, and EPIC-mCT was able to detect
these changes at both time points in our study. Although we
measured slight degenerative changes on histology and signiﬁcant
correlations between attenuation and these histologic ﬁndings in
the Puncture group, we did not ﬁnd a signiﬁcant increase in
attenuation in the Puncture group, and we, therefore, cannot
conclude that EPIC-mCT is sensitive to the degenerative changes of
annular puncture at or before six post-operative weeks. Thus,
future studies are necessary to assess later time points. A possible
explanation for the less-pronounced increase in attenuation in the
Puncture group is the inherent regenerative capacity of the rabbit
IVD due to remaining notochordal cells in the NP33, which have
been shown to provide regenerative potential in the IVD34. These
cells could have countered the degenerative cascades in the
Puncture group, whereas notochordal cells were likely removed in
the Nucleotomy group.
Formalin ﬁxation can prevent sample degradation and afford
greater standardization of sample processing with simpliﬁed
experimental design. Formalin ﬁxation has been previously shown
to affect attenuation in EPIC-mCT-imaged cartilaginous speci-
mens19. Benders and coworkers have shown that formalin ﬁxation
decreases attenuation of articular cartilage by ~14%19, similar to the
reduction of ~10.5% measured in our study. While the precise
mechanism of this reduction has not been fully elucidated, Benders
et al. indicate that this is likely due to changes in water content or
interaction between residual formalin and ioxaglate rather than
changes in sGAG content, as their data showed no signiﬁcant de-
creases in sGAG content due to ﬁxation. In our study, the decrease
in attenuation due to ﬁxation effectively decreased the dynamic
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degenerative changes when comparing absolute numbers between
groups. However, correlations between metrics of degeneration
and IVD attenuation maintained strength and signiﬁcant. Based on
these results, the use of EPIC-mCT following formalin ﬁxation can be
employed when studying advanced degeneration, but the
decreased sensitivity may need to be addressed by study design.
This study was not without limitations. Variability may be
attributed in part to scan resolution, an inherent limitation of im-
aging studies. A system with higher resolution would potentially
afford increased sensitivity due to a lower degree of volume aver-
aging at tissue interfaces. Scan-to-scan variability was minimized
by positioning the specimens in a consistent manner and using
identical scanning protocols. Furthermore, each surgical disc was
scanned with its own adjacent control, thereby allowing compari-
son to an internal control within a single scan. The presence of
highly attenuating tissue adjacent to the IVD can cause tomo-
graphic artifacts, reinforcing the importance of meticulous soft
tissue dissection before scanning. In this study, the presence of soft
tissue was adequately minimized, but not completely eliminated.
Future studies could implement a more comprehensive IVD isola-
tion protocol such as that outlined in Chan et al.4 to further reduce
the effect of beam hardening. There was an inherent level of bio-
logic variability in this study, especially within the Puncture group,
which is likely due in part to the relatively early time points chosen
for assessment. Future studies using surgical models of degenera-
tion could also utilize 12-week time points or longer to assure that
signiﬁcant degenerative changes have occurred.
In summary, the present study shows that EPIC-mCT is able to
characterize sGAG distribution and 3D morphology of the IVD due
to preferential exclusion of the contrast agent from sGAG-rich
areas. Following surgically-induced degeneration, we measured
increased attenuation within the rabbit IVD, and this attenuation
correlated highly with disc volume, histologic grade, and disc
height. EPIC-mCT is a suitable analysis technique to determine sGAG
distributions within the IVD and to augment other imaging mo-
dalities and histologic analyses in pre-clinical animal models
assessing IVD degeneration as well as regenerative approaches.
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